Author:
Kracht Patricia A. M.,Lieveld Faydra I.,Amelung Linde M.,Verstraete Carina J. R.,Mauser-Bunschoten Eveline P.,de Bruijne Joep,Siersema Peter D.,Hoepelman Andy I. M.,Arends Joop E.,van Erpecum Karel J.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical)
Reference44 articles.
1. Marcellin F, Roux P, Protopopescu C, Duracinsky M, Spire B, Carrieri MP. Patient-reported outcomes with direct-acting antivirals for the treatment of chronic hepatitis C: current knowledge and outstanding issues. Expert Rev Gastroenterol Hepatol. 2017;11:259–68.
2. van der Meer AJ, Veldt BJ, Feld JJ, Wedemeyer H, Dufour JF, Lammert F, Duarte-Rojo A, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. 2012;308:2584–93.
3. daCosta DiBonaventura M, Wagner J-S, Yuan Y, L’Italien G, Langley P, Ray Kim W. The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities. J Med Econ. 2011;14:253–61.
4. Gutteling JJ, De Man RA, Van der Plas SM, Schalm SW, Busschbach JJ, Darlington A-SE. Determinants of quality of life in chronic liver patients. Aliment Pharmacol Ther. 2006;23:1629–35.
5. Vietri J, Prajapati G, El Khoury AC. The burden of hepatitis C in Europe from the patients’ perspective: a survey in 5 countries. BMC Gastroenterol. 2013;13:16.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献